<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03732469</url>
  </required_header>
  <id_info>
    <org_study_id>00037883</org_study_id>
    <nct_id>NCT03732469</nct_id>
  </id_info>
  <brief_title>Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization</brief_title>
  <official_title>Administration of Rectal Acetaminophen During Oocyte Retrievals Reduces Post-Operative Opioid Utilization in Fertility Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to evaluate the administration of rectal acetaminophen to
      current and standard anesthesia and analgesia protocol in oocyte retrievals would reduce
      postoperative utilization of opioids (Tylenol with codeine) in fertility patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As the opioid epidemic shows no sign of abating, this national crisis deserves careful
      attention from all medical subspecialties. This includes reproductive endocrinology and
      infertility (REI), where opioids are primarily utilized for intraoperative and postoperative
      pain management for outpatient procedures such as oocyte retrievals, operative hysteroscopy,
      and laparoscopic myomectomy. The purpose of this study is to evaluate whether the
      administration of rectal acetaminophen in addition to the current, standard anesthesia and
      analgesia protocol in oocyte retrievals can help decrease utilization of prescribed opioid at
      home following oocyte retrieval. Rectal acetaminophen will be used rather than conventional
      IV acetaminophen because of the lack of access to IV acetaminophen at the study institution.
      Rectal acetaminophen is appealing because it is cheap, readily available in most medical
      centers and there is the potential for increased analgesic benefit due to the proximity to
      the vaginal and ovarian tissue, as well as the possible benefit from the partial avoidance of
      hepatic first-pass metabolism. This trial has the potential to provide practice-changing
      clinical information to the field of REI. The information gained can even translate to other
      ambulatory procedures and guide clinical practice. The investigators hypothesize that
      participants given rectal acetaminophen in addition to standard anesthesia/analgesia at the
      end of their oocyte retrieval will use less amount of prescribed Tylenol with codeine 3 days
      after discharge from the surgery center compared those receiving standard
      anesthesia/analgesia for oocyte retrieval.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of prescribed Tylenol with Codeine (Tylenol #3) utilized</measure>
    <time_frame>72 hours following oocyte retrieval</time_frame>
    <description>The proportion of prescribed Tylenol with Codeine (Tylenol #3) utilized 72 hours postoperatively will be assessed by telephone encounter. A total of 10 tablets of Tylenol #3 will be prescribed to each participant. Fewer Tylenol #3 used at the end of this time frame would indicate better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score in post-anesthesia care unit using the Visual Analog Scale</measure>
    <time_frame>1-hour after oocyte retrieval</time_frame>
    <description>The Visual Analog Scale will be used to assess postoperative pain 1-hour after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-hour pain score using the Visual Analog Scale</measure>
    <time_frame>24 hours after oocyte retrieval</time_frame>
    <description>The Visual Analog Scale will be used to assess pain 24 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>48-hour pain score using the Visual Analog Scale measuring pain</measure>
    <time_frame>48 hours after oocyte retrieval</time_frame>
    <description>The Visual Analog Scale will be used to assess pain 48 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>72-hour pain score using the Visual Analog Scale measuring pain</measure>
    <time_frame>72 hours after oocyte retrieval</time_frame>
    <description>The Visual Analog Scale will be used to assess pain 72 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Fentanyl/propofol + acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol, one dose of 1300 mg of solid base rectal acetaminophen suppository (2 suppositories) will be administered at the end of oocyte retrieval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl/propofol only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this arm will receive the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Rectal acetaminophen will be administered to the intervention group at the conclusion of the oocyte retrieval.</description>
    <arm_group_label>Fentanyl/propofol + acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Weight-based IV Fentanyl as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital</description>
    <arm_group_label>Fentanyl/propofol + acetaminophen</arm_group_label>
    <arm_group_label>Fentanyl/propofol only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Weight-based IV Propofol as a part of the standard anesthesia/analgesia induction protocol at Tampa General Hospital</description>
    <arm_group_label>Fentanyl/propofol + acetaminophen</arm_group_label>
    <arm_group_label>Fentanyl/propofol only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any female patient undergoing oocyte retrieval by transvaginal ultrasound-guided
             ovarian puncture

        Exclusion Criteria:

          -  Patients with chronic pain conditions such as fibromyalgia and sickle cell anemia.

          -  Patient with BMI greater than 40

          -  Patients that required general endotracheal intubation anesthesia in prior oocyte
             retrieval

          -  Patients with documented allergic reaction to acetaminophen

          -  Patient with contra-indication to the use of acetaminophen (liver disease)

          -  Patients with a history of past or current alcohol, drug or opioid abuse

          -  Patients with ulcerative colitis, Crohn's disease, or severe rectal hemorrhoids
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>56 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Imudia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clarissa Lam, MD</last_name>
    <phone>6463792934</phone>
    <email>clarissalam@health.usf.edu</email>
  </overall_contact>
  <reference>
    <citation>Ditkoff EC, Plumb J, Selick A, Sauer MV. Anesthesia practices in the United States common to in vitro fertilization (IVF) centers. J Assist Reprod Genet. 1997 Mar;14(3):145-7.</citation>
    <PMID>9090556</PMID>
  </reference>
  <reference>
    <citation>Fiebai PO, Ogunmokun AA, Ajayi RA. Experience with conscious sedation for oocyte retrieval in Nigeria. Afr J Reprod Health. 2008 Apr;12(1):30-4.</citation>
    <PMID>20695152</PMID>
  </reference>
  <reference>
    <citation>Singhal H, Premkumar PS, Chandy A, Kunjummen AT, Kamath MS. Patient Experience with Conscious Sedation as a Method of Pain Relief for Transvaginal Oocyte Retrieval: A Cross Sectional Study. J Hum Reprod Sci. 2017 Apr-Jun;10(2):119-123. doi: 10.4103/jhrs.JHRS_113_16.</citation>
    <PMID>28904501</PMID>
  </reference>
  <reference>
    <citation>Gejervall AL, Stener-Victorin E, Möller A, Janson PO, Werner C, Bergh C. Electro-acupuncture versus conventional analgesia: a comparison of pain levels during oocyte aspiration and patients' experiences of well-being after surgery. Hum Reprod. 2005 Mar;20(3):728-35. Epub 2004 Dec 17.</citation>
    <PMID>15608039</PMID>
  </reference>
  <reference>
    <citation>Özaltın S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol. 2018;89(1):1-6. doi: 10.5603/GP.a2018.0001.</citation>
    <PMID>29411339</PMID>
  </reference>
  <reference>
    <citation>Frederiksen Y, Mehlsen MY, Matthiesen SM, Zachariae R, Ingerslev HJ. Predictors of pain during oocyte retrieval. J Psychosom Obstet Gynaecol. 2017 Mar;38(1):21-29. doi: 10.1080/0167482X.2016.1235558. Epub 2016 Sep 27.</citation>
    <PMID>27670651</PMID>
  </reference>
  <reference>
    <citation>Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun 21;152(6):e170504. doi: 10.1001/jamasurg.2017.0504. Epub 2017 Jun 21. Erratum in: JAMA Surg. 2019 Mar 1;154(3):272.</citation>
    <PMID>28403427</PMID>
  </reference>
  <reference>
    <citation>van Hoogdalem E, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet. 1991 Jul;21(1):11-26. Review.</citation>
    <PMID>1717195</PMID>
  </reference>
  <reference>
    <citation>Julious SA. Sample sizes for clinical trials with normal data. Stat Med. 2004 Jun 30;23(12):1921-86. Review.</citation>
    <PMID>15195324</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 31, 2018</study_first_submitted>
  <study_first_submitted_qc>November 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>egg retrieval</keyword>
  <keyword>oocyte retrieval</keyword>
  <keyword>opioid dependence</keyword>
  <keyword>rectal acetaminophen</keyword>
  <keyword>rectal tylenol</keyword>
  <keyword>pain</keyword>
  <keyword>opioid use</keyword>
  <keyword>opioid abuse</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

